Xtant Medical Holdings Inc (NYSEAMERICAN:XTNT) saw a large drop in short interest during the month of August. As of August 31st, there was short interest totalling 22,200 shares, a drop of 30.0% from the July 31st total of 31,700 shares. Currently, 0.2% of the company’s shares are sold short. Based on an average daily volume of 3,200 shares, the short-interest ratio is presently 6.9 days.

Separately, Maxim Group lowered shares of Xtant Medical from a “buy” rating to a “hold” rating in a research report on Friday, May 17th.

XTNT traded down $0.04 during trading on Wednesday, hitting $2.70. The company’s stock had a trading volume of 2,000 shares, compared to its average volume of 7,266. Xtant Medical has a twelve month low of $1.61 and a twelve month high of $4.88.

Xtant Medical (NYSEAMERICAN:XTNT) last posted its quarterly earnings data on Thursday, August 8th. The medical device company reported ($0.15) earnings per share (EPS) for the quarter. The firm had revenue of $15.27 million during the quarter.

About Xtant Medical

Xtant Medical Holdings, Inc, formerly Bacterin International Holdings, Inc, develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets. The Company operates through the development, manufacture and marketing of regenerative medical products and devices segment.

See Also: Percentage Gainers

Receive News & Ratings for Xtant Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xtant Medical and related companies with MarketBeat.com's FREE daily email newsletter.